Amanda J. King-Ahmad

In Vitro-In Vivo Extrapolation of Intestinal Availability for Carboxylesterase Substrates Using Portal Vein-Cannulated Monkey.

T. Maurer, D. Scott, K. Beaumont, 2017, Journal of pharmaceutical sciences.

A sensitive method for the quantitation of the peptide-based glucagon-like peptide-1 receptor agonist liraglutide in plasma using microfluidics chromatography tandem MS.

A. Kalgutkar, C. Holliman, H. Eng, 2018, Bioanalysis.

Effect of a Ketohexokinase Inhibitor (PF‐06835919) on In Vivo OATP1B Activity: Integrative Risk Assessment Using Endogenous Biomarker and a Probe Drug

A. D. Rodrigues, M. Varma, A. Bergman, 2022, Clinical pharmacology and therapeutics.

Dose‐Dependent Inhibition of OATP1B by Rifampicin in Healthy Volunteers: Comprehensive Evaluation of Candidate Biomarkers and OATP1B Probe Drugs

H. Kusuhara, Y. Sugiyama, E. Kimoto, 2020, Clinical pharmacology and therapeutics.

A fully automated and validated human plasma LC-MS/MS assay for endogenous OATP biomarkers coproporphyrin-I and coproporphyrin-III.

A. D. Rodrigues, Fumin Li, C. Holliman, 2018, Bioanalysis.

A highly selective and sensitive LC-MS/HRMS assay for quantifying coproporphyrins as organic anion-transporting peptide biomarkers.

A. D. Rodrigues, C. Holliman, R. Ramanathan, 2017, Bioanalysis.

Pharmacokinetics, mass balance, metabolism, and excretion of the liver-targeted acetyl-CoA carboxylase inhibitor PF-05221304 (clesacostat) in humans

A. Kalgutkar, A. Bergman, T. E. Ballard, 2022, Xenobiotica; the fate of foreign compounds in biological systems.

The use of plasma aldosterone and urinary sodium to potassium ratio as translatable quantitative biomarkers of mineralocorticoid receptor antagonism

P. Loria, V. Sahasrabudhe, M. Banker, 2011, Journal of Translational Medicine.

Efficient Liver Targeting by Polyvalent Display of a Compact Ligand for the Asialoglycoprotein Receptor.

M. Ammirati, David A. Price, S. Liras, 2017, Journal of the American Chemical Society.